Member Info for Pacman121

I know but an automated lab isn't going to be running a low amount of tests is it? so by default, an interested party will be getting through a lot, otherwise the Biomek isn't cost-effective, unless of course they already have one for other tests, The 96 plate well is a standard.

Not to be confused with the EUA! (FDA US thing)

Can anyone remeber where we got to with the EUL, as in World Health Organisation Emergency use listing?
There was an update today but I honestly can't remeber where GDR was at before.

Preefty I think I was just showing how a relatively small number equals big bucks. Also wasn't really thinking about it on a lab basis, more so against the 1.8m tests US is doing everyday, and the the fact that BC ramped up there antigen tests to 35,000 a month to meet demand. Even the recently fully automated BC test doesnt have an EUA yet and they are getting through more than ever. Thats why I thought 350 PCR tests a month didn't seem a far cry. You're probably right tho, as GDR's test is designed to be used on a 96 plate well, and you only get 10 in a box, I suppose labs would need more than 1 if they are going to make the shiny Biomeki7 or Themofisher, or whatever other compatible automation machine worthwhile. They can of course just use the kit manually if they just wanted to buy one for sh1|s and giggles.

@Posh

They have already said that testing will remain standard to safeguard against future pandemics. Covid caught the planet off guard and killed nearly 4m people. Structures will be put in place to monitor and be prepared for the next one. Pollution, meat markets and general filthy environments are all breeding grounds for these and as they get worse the strength of the virusus is higher.

And yes flu testing is done, thats how flu jabs are made every year.

Well that was a serious flush today. No idea who is selling all the way down here but i did get a nice chunk to add to existing holding which felt good. We'll see what happens for the rest of the week and then next week.

No idea why we have done so much volume suddenly or why we have dropped. I get people are loading up on a cheap entry but a lot must have exited at near lows which must have been costly. A few large sells today too creating a sub 50p entry. Hope theres no foul play there. If only the BOD (who need to go) could engage a bit, it would do wonders. Even RNS'ing the AIHL thing for August would be something, an update on India - they dont want us/waiting for regulation/Divoc are waiting with orders to fill. Anything really.

Beckman must of sold a few kits. Like I said a couple of weeks back, even if they have only sold 1000, thats £10m to GDR which underpins financing and the market cap. If they haven't sold any then I'd be more worried about Danaher as a life sciences entity.

Lots of new money entering and averaging down today no doubt today so everyone should feel at least a little better for that, albeit we have been slammed.

Looking forward to the next 2 weeks to get some closure.

Honestly don't know. But if they do I'm sure Beckman will add it to their inventory and will likely get first dibs to do so.

We're at a 4month low. Strange time to be offloading?

@Pokerchips

I get what you're saying, and agreed with you up to a point, but I'm now on the other side of that line. This is snowballing and needs to be addressed immediately.

@ Prefty

Hi mate. So we assumed given how quickly the ICMR clinically approved the test, same week, there may be a sense of urgency behind actually getting into labs. There kinda is but the paperwork to get it into to country is a process that still needs to happen (yes despite the situation). No timeframes but I suspect that is what is arresting the progress there. A twitter poster actually posted the formal entry process soon after the developmnt of India using CE tests.

They've had their chance. They get paid either way so how bothered are they? Approach way too placid. POC might emerge in the next week or so, they were only tweaking it, 12 weeks seemed like a long time given how long the majority of development took.

Walbrook said something about regulatory paperwork for India so I assume import stuff. There will be some movement there which might be enough to get us going again from down here.

AIHL will be a big hit in US and UK. Thats being drummed up in August I think so that will def get us back to where we were as the take up looks genuine on that one. What happens inbetween is anyones guess.

Things happening around the HCV:
https://www.researchgate.net/publication/351078214_Diagnostic_Performance_and_Usability_of_the_GenedriveR_HCV_ID_Kit_in_Two_Decentralized_Settings_in_Cameroon_and_Georgia

BUT I'll be voting BOD down for sure. It's just a case of enough is enough now. Simple as that.

AGM I mean?

?

@Pokerchips

I'm pro-GDR and take your point about the promise thing. A number of things were out of GDR's hands, like FDA delay, and some made assumptions in the wrong direction on that one. Investors however should not be kept in the dark, particularly when deadlines have been missed and delayed as often a they have here (a deadline is as good a promise as you get here). Day traders don't need to be kept upto date but those that hold long term and wactch their investment dwindle on a daily basis with limited understanding or reason as to why deserve the attention of those responsible. If they were on top of things then fair enough they can be as arrogant as they like, when they let investors down a company should be far more proactive - which this board are not. They have done a great job with the product range, but are not suited for the next steps. Look at their salaries. 100% need to be aligned with performance now which is why I am keen to see a new board elected at the next AGM. Something could well be going on in the background, and probably is, but its really like investors have been shunted on this one. Why a company with multiple products including a world first hearing test are not making more noise is peculiar. Being kept out of the loop on PCR sales is ridiculous. If they cant give BC number thats fine, just tell us how many beads GDR have sold - thats not forward looking - totally in the past. If that POC test has been delayed (again) with not a single update since the last delay then BOD need to go. Again, products great, attitude needs alignment. Even if the SP hit £3 tomorrow, that doesn't change the point - although no one here would care past the £3 if we're honest.

@jace No you haven't. No one would serial badger £60k of their own money like you have.

Jac/Myluck isn't holding. Absolutely no way. Probably never has.

get to sell down their last 700k this month? Is that accurate? Think they sold the other 2m in Feb. Basically taking their paycheck for the loan. On the road and can't remeber exact numbers but there wasn't much. About a days volume at current levels. PI's could be selling of course, they are the ones that took it down to 40p before the 8 day shoot up to 165p.

Products are good. They could and should have arrested the sentiment decline.

New team of directors needed. Not blaming them for delays but am blaming them for arrogance. Vote them out.

They've said they might release an update for the quarter in early July. By its definition that should include BC sales, or at least beads sold to whoever.

@rbr08

Hi mate, replying to your earlier question if you're still about. So, as you may know, Cytivia the manufacturing partner (10,000+ per hour etc) have the same parent company (Danaher) as Beckman Coulter. This essentially cuts out GDR from having to actually handle/process the stock as BC and Cytivia already have internal logistics. I'm not sure if you also meant would GDR be totally cut out? So to try to answer it anyway I don't think they will be cut out at all, they just don't need to do the physical bit due to the existing relationship if that makes sense. I'm not suggesting they will be taken out of the loop in anyway and should be fully up to speed on sales.

I agree. Products are great and in the hands of bigger players now. But the arrogant standing towards shareholders is too much for most to bear. There have been delays and so shareholders need to be kept more updated than GDR like to do as this is AIM. Don't forget it's the day traders that attack the PR companies and GDR for off-the-cuff info to try and support their position. That's fine but they shouldn't call themselves investors.

I'm confident we are selling via Beckman. Don't forget they get the stock directly through Cytivia so GDR don't really need to do much other than take their cut. SP is dwindling on low volume as retail investors just can't be bothered with it all anymore. The immense negativity and repetition for the few on here is highly depressing to sort through, and they are winning in the absence of anything at all from the company.

I personally think the board has done a reasonable job in getting products developed and to market and also done well with the distribution partners. But I think it's time they were replaced with a more social bunch as that is where we are now. Also salaries need to be in line with sales performance at this point.

Happy where we are as a company, not happy with SP obviously as take away the chronic wingers and sentiment may be better than it is now. Not sure when the BC update will come, I know it won't necessarily be a part of the quarterly update, if we get one (not a consistent thing) but hopefully we will or hopefully BC will update the market directly. Not sure how long we can be kept in the dark on that one. AIHL should be progressing now so we are also owed an update on that one as we are in the middle of summer. If this all turns out to be more bul1**** then we all need to focus our time to adding up holdings and voting in a new board. You wingers can head that one up as the time you have on your hands seems to be unrivaled. But on a serious note shareholders have the ultimate power and I know quite a few holders in excess of £100k.